does tirzepatide have cardiovascular benefits and Health: A Comprehensive Overview The Cardiovascular Effect of Tirzepatide:

Pharmacodynamic Effects and Duration Despite measurable plasma clearance, pharmacodynamic effects extend well beyond plasma half-life[20]: Weight loss effects continue throughout treatment with no plateau observed within 48-week study periods Glycemic improvements persist between weekly doses with stable glucose control Appetite suppression effects remain consistent throughout dosing intervals Tissue receptor occupancy likely exceeds plasma peptide concentrations This disconnect between pharmacokinetics and pharmacodynamics suggests prolonged receptor engagement, tissue depot effects, or persistent downstream signaling cascade activation

A drug could also act by inhibiting activation of T cells or by binding up tTGase so that gluten was not broken down into toxic peptides

Preliminary results

Viability depends primarily on which solvent was used and how consistently the solution has been stored